DIA-TOPRA Workshop on Falsified Medicines

This conference will take stock of where we stand in the EU on falsified medicines and paint the landscape of the global issue. The speakers will present the approaches of the Member States on the implementation of the new legislation, and the impact and achievements of the concerned stakeholders such as industry, patients, pharmacies and distributors who have worked independently and together to find solutions.

Back to Agenda

Session 1 – The views from the European Commission and Member States

Session Chair(s)

Hugo Bonar

Enforcement Manager

Health Products Authority, Ireland

Speaker(s)

Views from the European Commission

Patrizia Tosetti, PhD

European Commission - DG Health and Food Safety, Belgium

Policy Officer

Views from Belgium

Philippe De Buck, MPharm

FAGG-AFMPS, Belgium

Head of Authorisations

Views from Luxembourg

Marcin Wisniewski

Ministry of Health, Luxembourg

Views from Spain

Belen Escribano Romero, PharmD, MPA

AEMPS, Spain

Head of Department, Pharmaceutical Inspection and Enforcement

Views from UK

Jan MacDonald, MSc, RPh

MHRA, United Kingdom

Group Manager for AIMS

EMVO-EDQM Conformity Assessment

Francois Lery, PharmD, PhD

WHO, France

Coordinator for Technologies, Standards and Norms

Have an account?